Hem/Onc Section Partners with Bristol-Myers Squibb for Cancer Research

Street Insider publishes article “Bristol-Myers Squibb (BMY) Announces Research Collaboration with Boston Medical Center to Investigate Markers of Immuno-Oncology Response & Resistance”

The hematology/oncology section at Boston Medical Center is partnering with Bristol-Meyers Squibb to investigate biomarkers in a variety of cancers to predict Immuno-Oncology I-O responses.

We look forward to partnering with Bristol-Myers Squibb on this study to identify and assess biomarkers across a diverse patient population, providing us with a deeper and more comprehensive understanding of I-O resistance.” – Dr. Matt Kulke, BMC Chief of Hematology/Oncology Section

Read More

View all posts